Recruiting
Phase 2

Sponsor:

Yale University

Code:

NCT05067621

Conditions

Type 2 Diabetes Mellitus

Impaired Glucose Tolerance

Non-Alcoholic Fatty Liver Disease

Obesity, Childhood

Eligibility Criteria

Sex: All

Age: 10 - 21

Healthy Volunteers: Not accepted

Interventions

Semaglutide Pen Injector

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Yale University on 2025-05-21.